WP
AVEO

Woodline Partners’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Woodline Partners’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-548,191
Closed -$8.2M – 940
2022
Q4 		$8.2M Buy
+548,191
New +$7.59M 0.11% 242

Woodline Partners's AVEO Position: Q1 2023 in Review

Woodline Partners sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 548,191 shares — an estimated $8.2M sold.

Woodline Partners first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $8.2M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Woodline Partners reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Woodline Partners sold 548,191 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $8.2M.
  • Woodline Partners first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Woodline Partners's AVEO Pharmaceuticals, Inc. position peaked at $8.2M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Woodline Partners's 13F filing for Q1 2023, filed 15 May 2023.